Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced an underwritten public offering of 5,375,000 of its ordinary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE